TORL BioTherapeutics
TORL BioTherapeutics is a clinical-stage biotechnology company focused on discovering and developing antibody-based immunotherapies for cancer. They are developing a pipeline of antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs) targeting specific antigens overexpressed in cancer cells. Their work is based on a strategic partnership with the Slamon Research Lab at UCLA.
Buy Funded Startups lists
Funding Round: Series B2
Funding Amount: $158M
Date: 10-Apr-2024
Investors: Deep Track Capital, RA Capital Management, Perceptive Advisors, Avidity Partners, Goldman Sachs Alternatives, UC Investments, Bristol Myers Squibb, Vertex Ventures HC, Moore Strategic Ventures, Blue Owl Healthcare Opportunities, Perceptive Xontogeny Venture Fund
Markets: Biotechnology, Oncology, Immunotherapy, Biopharma, Clinical Trials, Drug Discovery
HQ: Culver City, California, United States
Founded: 2018
Website: https://torlbio.com/
LinkedIn: https://www.linkedin.com/company/torl-biotherapeutics-llc
Crunchbase: https://www.crunchbase.com/organization/torl-biotherapeutics
Leave a Comment
Comments
No comments yet.